| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |